Description
EPO Monoclonal Antibody
| Catalog number: | B2015338 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 10 g |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | EPO Monoclonal antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang M, Sui W, Cheng C, Xue F, Tian Z, Cheng J, Zhang J, Zhang T, Zhang J, Wang W, Xiong W, Hao P, Ma J, Xu X, Wang S, Sun S, Zhang M, Zhang Y, Zhang C. Erythropoietin promotes abdominal aortic aneurysms in mice through angiogenesis and inflammatory infiltration Sci Transl Med. 2021 Jul 21;13(603):eaaz4959.
- Sykes DB, OConnell C, Schroyens W. The TEMPI syndrome Blood. 2020 Apr 9;135(15):1199-1203.
- Au L, Larkin J, Turajlic S. Relatlimab and nivolumab in the treatment of melanoma Cell. 2022 Dec 22;185(26):4866-4869.
- Oregovomab: anti-CA-125 monoclonal antibody B43.13AltaRex, B43.13, MAb B43.13, monoclonal antibody B43.13 Drugs R D. 2006;7(6):379-83.
- Debeljak N, Sytkowski AJ. Erythropoietin and erythropoiesis stimulating agents Drug Test Anal. 2012 Nov;4(11):805-12.
- Reichel C, Benetka W, Lorenc B, Thevis M. Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control Drug Test Anal. 2016 Nov;8(11-12):1131-1137.
- Tovey MG, Lallemand C. Immunogenicity and other problems associated with the use of biopharmaceuticals Ther Adv Drug Saf. 2011 Jun;2(3):113-28.
- DAndrea AD, Rup BJ, Fisher MJ, Jones S. Anti-erythropoietin receptor (EPO-R) monoclonal antibodies inhibit erythropoietin binding and neutralize bioactivity Blood. 1993 Jul 1;82(1):46-52.
- Sadahira Y, Mori M. Role of the macrophage in erythropoiesis Pathol Int. 1999 Oct;49(10):841-8.
